51 related articles for article (PubMed ID: 12599433)
1. [The effects of cholecystokinin octapeptide on PKC activity in rat cerebral cortex neurocytes].
Xiang P; Qiu M; Du Z; Chen M; Wu Z
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):72-4, 120. PubMed ID: 12599433
[TBL] [Abstract][Full Text] [Related]
2. CCKB receptor stimulation mediates [Ca2+]i increase but no PKC activation in Jurkat T-cells.
Kaufmann R; Lindschau C; Buchner K; Ott T
Neuroreport; 1992 Aug; 3(8):697-9. PubMed ID: 1520857
[TBL] [Abstract][Full Text] [Related]
3. CholecystokininA and cholecystokininB receptors in neurons of the brainstem solitary complex of the rat: pharmacological identification.
Branchereau P; Böhme GA; Champagnat J; Morin-Surun MP; Durieux C; Blanchard JC; Roques BP; Denavit-Saubié M
J Pharmacol Exp Ther; 1992 Mar; 260(3):1433-40. PubMed ID: 1545402
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic effect of CCK-8 on morphine-inhibited electrical and contractile activities of rat jejunum in vitro.
Xu MY; Yang DX; Wang SZ; Jin HB; Zou XH; Yang XP; Han JS
Sheng Li Xue Bao; 1998 Aug; 50(4):469-73. PubMed ID: 11324560
[TBL] [Abstract][Full Text] [Related]
5. Effect of cholecystokinin octapeptide on diacylglycerol-PKC signaling pathway in rat pulmonary interstitial macrophages stimulated by lipopolysaccharide.
Xu SJ; Gao WJ; Cong B; Ma CL; Li SJ; Ling YL; Gu ZY; Yao YX
Acta Pharmacol Sin; 2005 Dec; 26(12):1497-504. PubMed ID: 16297350
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.
Harper EA; Griffin EP; Shankley NP; Black JW
Br J Pharmacol; 1999 Mar; 126(6):1496-503. PubMed ID: 10217545
[TBL] [Abstract][Full Text] [Related]
7. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
Pu SF; Han JS
Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
[TBL] [Abstract][Full Text] [Related]
8. CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens.
Daugé V; Steimes P; Derrien M; Beau N; Roques BP; Féger J
Pharmacol Biochem Behav; 1989 Sep; 34(1):157-63. PubMed ID: 2626446
[TBL] [Abstract][Full Text] [Related]
9. Involvement of spinal cholecystokininB receptors in mediating neurotensin hyperalgesia from the medullary nucleus raphe magnus in the rat.
Urban MO; Smith DJ; Gebhart GF
J Pharmacol Exp Ther; 1996 Jul; 278(1):90-6. PubMed ID: 8764339
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the binding of a novel radioligand to CCKB/gastrin receptors in membranes from rat cerebral cortex.
Harper EA; Shankley NP; Black JW
Br J Pharmacol; 1999 Mar; 126(6):1504-12. PubMed ID: 10217546
[TBL] [Abstract][Full Text] [Related]
11. The antagonistic effect of cholecystokinin octapeptide (CCK-8) on opioid effects in cardiovascular activities was mediated by CCK-B receptor.
Mei L; Han JS
Sci China B; 1993 Jul; 36(7):817-23. PubMed ID: 8216742
[TBL] [Abstract][Full Text] [Related]
12. L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity.
Soar J; Hewson G; Leighton GE; Hill RG; Hughes J
Pharmacol Biochem Behav; 1989 Jul; 33(3):637-40. PubMed ID: 2587606
[TBL] [Abstract][Full Text] [Related]
13. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats.
Wu CL; Doong ML; Wang PS
Eur J Pharmacol; 2008 Feb; 580(3):407-15. PubMed ID: 18078924
[TBL] [Abstract][Full Text] [Related]
14. Role of cholecystokinin receptors in induction of antinociception in hot-plate test.
Rezayat M; Rahnavard A; Zarrindast MR
Pharmacol Toxicol; 2000 Aug; 87(2):58-62. PubMed ID: 10989941
[TBL] [Abstract][Full Text] [Related]
15. Peripheral cholecystokinin A and cholecystokinin B receptors mediate stimulation of gastric pepsinogen and acid secretion following intracerebroventricular injection of cholecystokinin-8-sulphate.
Blandizzi C; Lazzeri G; Carignani D; Colucci R; Baschiera F; Tognetti M; Placanica G; Del Tacca M
Ital J Gastroenterol Hepatol; 1999; 31(6):440-8. PubMed ID: 10575559
[TBL] [Abstract][Full Text] [Related]
16. The effects of cholecystokinin A and B receptor antagonists, devazepide and L 365260, on citalopram-induced decrease of exploratory behaviour in rat.
Matto V; Harro J; Allikmets L
J Physiol Pharmacol; 1996 Dec; 47(4):661-9. PubMed ID: 9116333
[TBL] [Abstract][Full Text] [Related]
17. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
[TBL] [Abstract][Full Text] [Related]
18. Effect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behavior and sensitization to amphetamine.
Alttoa A; Harro J
Eur Neuropsychopharmacol; 2004 Aug; 14(4):324-31. PubMed ID: 15163443
[TBL] [Abstract][Full Text] [Related]
19. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat.
Gronier B; Debonnel G
Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977
[TBL] [Abstract][Full Text] [Related]
20. Concerted action of cytosolic Ca2+ and protein kinase C in receptor-mediated phospholipase D activation in Chinese hamster ovary cells expressing the cholecystokinin-A receptor.
Bosch RR; Smeets RL; Sleutels F; Patel AM; Emst-de Vries SE; Joep J; de Pont HH; Willems PH
Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):263-8. PubMed ID: 9882623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
